Page 40 - Human Use News Today

Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer – paving the way for marketing authorisation by the continent's regulatory body.

London stocks looked set for a positive open on Monday as oil prices rose due to ongoing tensions in the Middle East.

GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer. The Brentford,...

RAHWAY, N.J.--(BUSINESS WIRE)--Oct 16, 2023--

FTSE 100 up 31 points at 7,631 Shells share price hits all-time high Ocado falls as Barclays downgrades 4:40pm: FTSE closes higher amid hopes of diplomatic...

Novavax remains confident in the ongoing rollout of its updated XBB protein-based non-mRNA COVID-19 vaccine in the U.S. Following arrival in pharmacies and healthcare provider offices, and...

FTSE 100 up 31 points at 7,631 Shells share price hits all-time high Ocado falls as Barclays downgrades 4:40pm: FTSE closes higher amid hopes of diplomatic...

The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of dostarlimab plus chemotherapy for the treatment of adult patients with mismatch repair–deficient/microsatellite instability–high primary advanced or recurrent endometrial cancer.

/PRNewswire/ -- Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions through a comprehensive portfolio inclusive of...

Swiss drug maker Santhera Pharmaceuticals Holding AG (SPHDF.OB) announced Friday that European Commission's Committee for Medicinal Products for Human Use or CHMP adopted a positive opinion in favor of approval of AGAMREE (vamorolone) to treat Duchenne muscular dystrophy or DMD patients aged 4 years and older.